Lataa...
Renin-Angiotensin-Aldosterone Inhibitors and COVID-19
• There is a concern that renin–angiotensin–aldosterone system (RAAS) blockers increase susceptibility to coronavirus 2019 (COVID-19). • There no evidence that treatment with RAAS blockers worsens the course of COVID-19. • Discontinuation of RAAS blockers may exacerbate cardiovascular comorbidities....
Tallennettuna:
| Julkaisussa: | J Nurse Pract |
|---|---|
| Päätekijät: | , |
| Aineistotyyppi: | Artigo |
| Kieli: | Inglês |
| Julkaistu: |
Elsevier Inc.
2020
|
| Aiheet: | |
| Linkit: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7237918/ https://ncbi.nlm.nih.gov/pubmed/32834792 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.nurpra.2020.05.007 |
| Tagit: |
Lisää tagi
Ei tageja, Lisää ensimmäinen tagi!
|